CLASS III Drug recall · Reported 30 Mar 2022 · FDA Enforcement Report

Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL recalled

Olympia Compounding Pharmacy is recalling Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01, distributed nationwide in the US. The recall was initiated on 8 Mar 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot: D41C19 Exp. 4/19/22
Quantity recalled493 vials.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0720-2022
FDA event ID
89717
Recalling firm
Olympia Compounding Pharmacy, Orlando, FL
Classification
Class III
Status
Terminated
Recall initiated
8 Mar 2022
FDA classified
29 Mar 2022
Reported
30 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Undeclared Sulfites

Timeline

8 Mar 2022Recall initiated by company
29 Mar 2022Classified by FDA+21 days
30 Mar 2022Published in enforcement report+1 day

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Sub Potent

Product as listed by the FDA

Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01 mg/mL, Multi-Dose 10 mL vial, Each ML contains: 0.5% Chlorobutanol NF, 0.005% Edetate Disodium Dihydrate USP, 2.74% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 1% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0004-10

Where it was distributed

Nationwide in the USA including Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Sub Potent

Which lots are affected?

Lot: D41C19 Exp. 4/19/22

Where was it sold?

Nationwide in the USA including Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 89717

This product is part of a recall event; the main page for the event is Sermorelin Acetate Lyophilized powder for reconstitution recalled.

More recalls from Olympia Compounding Pharmacy

All 94

Other Formula F9 recalls

All 2